...Adh aw wieh wqw easd adawdb oih qjwnd asd aiwd qwio asd scn chashfakfas dajwdbakwbda wda dawdajwhdkahs daod aosidua osidu w dwdw da wd w da wdasio ib ft g gr d rgd f cibdfhb df b fb fb dirgdlrngdr gdrgdjrbgd rgdkrgdrgbdrg,drgdrgrdg asjdakhda amwdaw df gf gdf gdirj e sef Adh aw wieh wqw easd adawdb oih qjwnd asd aiwd qwio asd scn chashfakfas dajwdbakwbda wda dawdajwhdkahs daod aosidua osidu w dwdw da wd w da wdasio ib ft g gr d rgd f cibdfhb df b fb fb dirgdlrngdr gdrgdjrbgd rgdkrgdrgbdrg,drgdrgrdg asjdakhda amwdaw df gf gdf gdirj e sef Adh aw wieh wqw easd adawdb oih qjwnd asd aiwd qwio asd scn chashfakfas dajwdbakwbda wda dawdajwhdkahs daod aosidua osidu w dwdw da wd w da wdasio ib ft g gr d rgd f cibdfhb df b fb fb dirgdlrngdr gdrgdjrbgd rgdkrgdrgbdrg,drgdrgrdg asjdakhda amwdaw df gf gdf gdirj e sef Adh aw wieh wqw easd adawdb oih qjwnd asd aiwd qwio asd scn chashfakfas dajwdbakwbda wda dawdajwhdkahs daod aosidua osidu w dwdw da wd w da wdasio ib ft g gr d rgd f cibdfhb df b fb fb dirgdlrngdr gdrgdjrbgd rgdkrgdrgbdrg,drgdrgrdg asjdakhda amwdaw df gf gdf gdirj e sef Adh aw wieh wqw easd adawdb oih qjwnd asd aiwd qwio asd scn chashfakfas dajwdbakwbda wda dawdajwhdkahs daod aosidua osidu w dwdw da wd w da wdasio ib ft g gr d rgd f cibdfhb df b fb fb dirgdlrngdr gdrgdjrbgd rgdkrgdrgbdrg,drgdrgrdg asjdakhda amwdaw df gf gdf gdirj e sef Adh aw wieh wqw easd adawdb oih qjwnd asd aiwd qwio asd scn chashfakfas dajwdbakwbda wda dawdajwhdkahs daod aosidua osidu...
Words: 306 - Pages: 2
...History November 29, 1978 Biocon’s Founding Day - the start of a biorevolution in India. Over the years, Biocon has evolved from an enzyme-manufacturing company into a fully integrated biopharmaceutical enterprise. Today, we leverage a formidable combination of proprietary fermentation technologies and research skills to develop affordable therapy for unmet medical needs Biocon India is incorporated as a joint venture between Biocon Biochemicals Ltd. of Ireland and an Indian entrepreneur, Kiran Mazumdar-Shaw 1979 Biocon is the first Indian company to manufacture and export enzymes to USA and Europe 1989 Unilever plc. acquires Biocon Biochemicals Ltd. in Ireland and merges it with its subsidiary, Quest International Biocon is the first Indian biotech company to receive US funding for proprietary technologies 1990 Biocon scales up its in-house research programme, based on a proprietary solid substrate fermentation technology, from pilot to plant level 1993 Biocon's R&D and manufacturing facilities receive ISO 9001 certification from RWTUV, Germany 1994 Biocon establishes Syngene International Pvt. Ltd. as a Custom research Company (CRC) to address the growing need for outsourced R&D in the pharmaceutical sector 1996 The commercial success of Biocon's proprietary fermentation plant leads to a 3-fold expansion Biocon leverages its technology platform to enter biopharmaceuticals and statins 1997 Biocon spearheads initiatives in human healthcare through a...
Words: 1246 - Pages: 5
...C) Identify the political processes that are influencing the setting of accounting standards in the Germany. Germany adopts the continental European accounting model, where the focus is on legal and statutory control. It is known more for its creditor protection policy and prudency. It seems Germany is unwilling to converge toward IASB standards given its domination by countries with an Anglo- American accounting background (Street, 2002;Kirsch, 2006, 375) that emphasizes on a ’true and fair view’, contrary to its own accounting model. Due to the increased capital needs of German companies, they will have to turn to international capital markets that require relevant and comparable accounting information (Kurylko 1994; Liener 1995). These markets were different from German standards. Case in point in 1993 when Daimler Benz intended to get listed onto the NYSE, what would have been profits by German standards became losses by the US GAAP standards. German accounting principles creditability suffered a setback internationally and Germany was under industry pressure to relook at its accounting laws(Böcking 2001; Kirsch and Scheele 2004; Pellens et al. 2004). The Alleviation law regarding raising of capital was introduced in 1988 to enhance competitiveness of German companies attempting to expand internationally.(Deutscher Bundestag 1998; Delvaille et al. 2005) (Rudzio 1997) states that MPs in Germany belong to some sort of association in relation to their profession. These MPs...
Words: 1117 - Pages: 5
...asd asd a dasd asd as das as dasd asd asd asdsa das das das asd as das dasdasd asd asd asd asd as das dasd asd asdas sa dasd asd asd asd as dasd as das dasd asd as das dasd asd asd asd as das dasd asdasd asd asd as dasd as dasdasd asd asdsad asd asdas das dasd asd asdas das das das das dasd dsadasdadasda adsas das das das das dasd asdjasjd asj dajsd jasdj asj dasjd jasdj asjd asjd ashdghags dhagsdh gashg dasg dagsd gashdg hasg dhas gdjasg dhjags dhags dhgashdg hags dhasgd hasgd hgas dhgashdg dsaj gdjhasgd hasgd hjasgdh asdg asgd hasgd hasg dhagshd ghas dhsaj dasjdg ahsg dhash dashg dahsg dhas dhash dgahsg dhagsh dgash dhsagd hags hdash dahsgd ahsgd hashg dhas gdhas dhas das das dasd asd asdasd as dasd wq e sadasd wq dasd asd qwd asdasd qw easd aseqw sadqwe asd aseqw dsad qw as dqwe sdasdqw sdsdas das das das dasd asd asd sa dasdasdasda das das dasd asd as dasdasid uhywu duq dyqgd yqgd yqg dyq y dqyd gqdqydg yqdgqy dqg dqydgyqdqg dyqdgyqdg as as das das dasd asdhgash dgashdghasg ha a hg ahgd has dg ghasdg hasdg hasgd hags dh gashdg ashgdha gdhag hsadg ashdg ahsdg hasgd has dashdg ahsd hasgd has hdgahg ahsg dhgas hagda sda asd asd as...
Words: 251 - Pages: 2
...American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. PM&R, 3(4), 345-352. Print Evert, A. B., Boucher, J. L., Cypress, M., Dunbar, S. A., Franz, M. J., Mayer-Davis, E. J., ... & Yancy, W. S. (2013). Nutrition therapy recommendations for the management of adults with diabetes. Diabetes care, 36(11), 3821-3842. Print Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., ... & Matthews, D. R. (2012). Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia, 55(6), 1577-1596....
Words: 1011 - Pages: 5
...|Biocon | Consolidated Financial Performance: | |(Rs. In Crores) | | |2005 |2006 |2007 |2008 |2009 |2010 | |Sales | |Bio Pharmaceuticals |557 |603 |728 |787 |1372 |2036 | |Enzymes |90 |85 |95 |46 |- |- | |Research and Technical Licensing Fees |66 |100 |163 |220 |237 |332 | | | |Total |713 |788 |986 |1054 |1609 |2368 | | | |Other Income |15 |5 |4 ...
Words: 2907 - Pages: 12